Duarte Ira (CIK 1488864) reported 14 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy HRTX (12,500 shares), Sell HRTX (3,555 shares), Buy HRTX (3,874 shares), Buy HRTX (11,695 shares), Buy HRTX (3,875 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 12,500 | $0 |
| 2026-06-17 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Sell | 3,555 | $1,351 |
| 2026-04-21 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 3,874 | $0 |
| 2026-02-03 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 11,695 | $0 |
| 2026-01-20 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 3,875 | $0 |
| 2025-11-04 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 11,694 | $0 |
| 2025-10-21 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 3,874 | $0 |
| 2025-08-04 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 11,695 | $0 |
| 2025-07-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 3,874 | $0 |
| 2025-06-25 | TerrAscend Corp. (TSNDF) | Director | Buy | 433,653 | $0 |
| 2025-06-17 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 12,500 | $0 |
| 2025-05-02 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 11,694 | $0 |
| 2025-04-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 3,875 | $0 |
| 2025-01-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Financial Officer | Buy | 3,874 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17